In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103.
Spriano F, Tarantelli C, Arribas AJ, Gaudio E, Cascione L, Aresu L, Rinaldi A, Zucca E, Rossi D, Stathis A, Murone M, Radtke F, Lehal R, Bertoni F.
Spriano F, et al. Among authors: bertoni f.
Br J Haematol. 2023 Mar;200(5):669-672. doi: 10.1111/bjh.18576. Epub 2022 Dec 9.
Br J Haematol. 2023.
PMID: 36484636
No abstract available.